Marketing tissue products in the EU: frustrations and hazards
This article was originally published in Clinica
Any manufacturer who attempts to break into one of the EU member state markets with a tissue engineered medical device is making a bold, costly and potentially risky decision. So is it worth it? That was the question that was being addressed at the Management Forum meeting in London on Human Tissue Products on November 19 2003.